Diagnostic accuracy of covid-19 rapid antigen tests with unsupervised self-sampling in people with symptoms in the omicron period: cross sectional study

In this paper by Schuit and colleagues (BMJ 2022;378:e071215, doi:10.1136/bmj-2022-071215, published 14 September 2022), sensitivities of the MPBio and Clinitest rapid antigen tests were transposed in the What this study adds section of the summary points box. The text should have read: The sensitivities of three commercially available rapid antigen tests performed with nasal self-sampling decreased during the emergence of omicron, from 87% to 81% for Flowflex, 80% to 73% for MPBio, and 83% to 70% for Clinitest, with only Clinitest reaching statistical significance.
Read Original Article: Diagnostic accuracy of covid-19 rapid antigen tests with unsupervised self-sampling in people with symptoms in the omicron period: cross sectional study »